Roche and CuraGen have announced that they have signed a definitive agreement under which Roche will acquire 100% of 454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, active in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback